Aller au contenu
AusGrant
UE Ouvert EU-FUNDING-PORTAL-HORIZON-HLTH-2023-CARE-08-01

European Partnership on Personalised Medicine

European Commission (EC) · Compétitif · Horizon Europe

En bref

European Partnership on Personalised Medicine est une aide à l'échelle de l'UE de type « Compétitif » proposée par European Commission. Financement : Jusqu'à €37M. Candidats éligibles : Open to eligible organisations in EU Member States and Horizon Europe associated countries; consortium requirements vary by topic - see the official call conditions. La date limite de candidature est le 20 janvier 2027. Candidatez via l'annonce officielle sur ec.europa.eu.

Montant
Jusqu'à €37M
Date limite
20 janv. 2027
Type
Compétitif
Statut
Ouvert

Le programme

With this JTC, EP PerMed will fund research projects in human health on Cell and Gene Therapies (CGT) for PM approaches. Proposals must focus on the development and validation of an innovative and novel CGT for PM.At least one of the following approaches must be employed:Somatic cell therapeutics;Gene therapeutics;Combined cell- and gene therapeutics;Novel biological products.For the entire scope, please consult the Call Text: https://www.eppermed.eu/funding-projects/calls/jtc2027/.

Qui peut candidater

Open to eligible organisations in EU Member States and Horizon Europe associated countries; consortium requirements vary by topic - see the official call conditions.

Comment candidater

Apply through the EU Funding & Tenders portal; submission is electronic via the portal's Submission Service before the topic deadline.

Candidater sur la source officielle